| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
FA complementation group F | 0.535 | 0.731 | 0.46 |
|
disease | 0.510 | strong | 1.000 | 1 | 0 | 2003 | 2017 | ||||||||
|
FA complementation group G | 0.556 | 0.769 | 2.5E-14 |
|
disease | 0.510 | strong | 1.000 | 1 | 0 | 2016 | 2017 | ||||||||
|
cysteine rich hydrophobic domain 2 | 0.769 | 0.231 | 0.54 |
|
disease | 0.410 | None | 1.000 | 1 | 0 | 1999 | 1999 | ||||||||
|
LIM domain containing preferred translocation partner in lipoma | 0.543 | 0.769 | 7.2E-03 |
|
disease | 0.410 | None | 1.000 | 1 | 0 | 2001 | 2001 | ||||||||
|
charged multivesicular body protein 5 | 0.751 | 0.192 | 6.7E-03 |
|
disease | 0.410 | None | 1.000 | 1 | 0 | 2007 | 2017 | ||||||||
|
cystatin C | 0.436 | 0.808 | 3.9E-03 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2005 | 2007 | ||||||||
|
four and a half LIM domains 2 | 0.556 | 0.731 | 2.9E-05 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2007 | 2019 | ||||||||
|
annexin A5 | 0.458 | 0.769 | 3.8E-15 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2000 | 2007 | ||||||||
|
EH domain containing 3 | 0.729 | 0.308 | 4.2E-02 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
inhibitor of DNA binding 2 | 0.572 | 0.731 | 0.67 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2007 | 2017 | ||||||||
|
FA complementation group L | 0.551 | 0.731 | 5.9E-23 |
|
disease | 0.310 | strong | 1.000 | 1 | 0 | 1999 | 2017 | ||||||||
|
regulator of G protein signaling 2 | 0.561 | 0.769 | 5.7E-06 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2005 | 2007 | ||||||||
|
S100 calcium binding protein A10 | 0.528 | 0.769 | 0.17 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2007 | 2018 | ||||||||
|
sprouty RTK signaling antagonist 4 | 0.553 | 0.769 | 4.8E-04 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2015 | 2017 | ||||||||
|
Cbl proto-oncogene B | 0.691 | 0.423 | 1.00 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
collagen type XVIII alpha 1 chain | 0.449 | 0.808 | 1.7E-10 |
|
disease | 0.120 | None | 1.000 | 1 | 1 | 2002 | 2017 | ||||||||
|
forkhead box N3 | 0.686 | 0.538 | 0.93 |
|
disease | 0.110 | None | 1.000 | 1 | 0 | 2017 | 2019 | ||||||||
|
egl-9 family hypoxia inducible factor 3 | 0.575 | 0.654 | 9.5E-03 |
|
disease | 0.110 | None | 1.000 | 1 | 0 | 2016 | 2017 | ||||||||
|
ceruloplasmin | 0.466 | 0.846 | 4.2E-10 |
|
disease | 0.110 | None | 1.000 | 1 | 0 | 2010 | 2017 | ||||||||
|
sarcoglycan zeta | 0.751 | 0.385 | 6.4E-09 |
|
disease | 0.110 | None | 1.000 | 1 | 0 | 2014 | 2017 | ||||||||
|
activating transcription factor 2 | 0.551 | 0.808 | 0.99 |
|
disease | 0.110 | None | 1.000 | 1 | 0 | 2017 | 2018 | ||||||||
|
C-type lectin domain family 4 member C | 0.678 | 0.500 | 5.8E-07 |
|
disease | 0.110 | None | 1.000 | 1 | 0 | 2013 | 2017 | ||||||||
|
dyskerin pseudouridine synthase 1 | 0.547 | 0.769 | 1.00 |
|
disease | 0.110 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
dipeptidyl peptidase like 6 | 0.603 | 0.692 | 0.34 |
|
disease | 0.110 | None | 1.000 | 1 | 0 | 2012 | 2017 | ||||||||
|
EBF transcription factor 1 | 0.584 | 0.654 | 1.00 |
|
disease | 0.110 | None | 1.000 | 1 | 0 | 2015 | 2017 |